What is Daiken Medical Co., Ltd.'s (7775.T) StockRank?

MoatMap's StockRank for Daiken Medical Co., Ltd. (7775.T) is 77/100, with a Buy signal. This is a composite score combining Quality (65), Value (51), and Momentum (49) factor ranks across MoatMap's 20,000+ stock universe.

Does Daiken Medical Co., Ltd. have an economic moat?

Daiken Medical Co., Ltd. (7775.T) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Daiken Medical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Daiken Medical Co., Ltd. (7775.T) is Buy, based on a StockRank of 77/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Daiken Medical Co., Ltd. in?

Daiken Medical Co., Ltd. (7775.T) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Japan).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

7775.T

BUYREMOVE

Daiken Medical Co., Ltd. · Healthcare · Japan · $77M · Avg Vol: $112K/d

StockRank

P/E (TTM)

13.1x

ROE

12.1%

D/E

0.3x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Daiken Medical manufactures medical devices for the Japanese market. It lacks the global scale, CDMO pricing power, or reinvestment runway required for our strategy.

COMPANY DESCRIPTION

Daiken Medical Co., Ltd. develops, manufactures, and sells medical instruments and supplies, focusing on disposable balloon infusers for pain management and vacuum suction systems. The company holds a leading market share in Japan for patient-controlled analgesia (PCA) devices and hospital suction equipment. It operates as a highly specialized, R&D-driven medical technology provider with strong relationships across Japanese clinical networks.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	53M	57M	61M	62M	5.2%
EPS	0.18	0.15	0.22	0.24	9.7%
Shares	32M	32M	32M	32M	0.0%
Debt	18M	17M	13M	13M	-11.5%
Equity	40M	41M	44M	47M	5.3%
Op CF	7M	6M	10M	7M	-0.4%
Inv CF	-1M	-1M	-1M	-1M	—
Fin CF	-4M	-5M	-7M	-4M	—

PRICE (1M)-5.4%

SMA 50SMA 200

$2.64

RSI (14)

47.9

52W High

$2.98

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

18.2%89.8

ROE

12.1%76.6

GP/Assets

34.9%72.9

Op. Margin

6.7%59.0

FCF/Assets

1.5%55.7

Piotroski

—55.7

Int. Cover

50.0x91.5

D/E Ratio

0.29x43.9

Current Ratio

2.58x47.4

Value

P/E (TTM)

13.1x79.3

EV/EBITDA

7.5x50.9

P/FCF

11562.8x15.2

P/B

1.6x65.0

P/S

1.2x81.3

Div Yield

—N/A

Momentum

52W High %

89%86.8

RS 6M

-42%28.5

SMA 50/200

0.98x58.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—42.2

Q Growth

-42%13.9

FUNDAMENTALS

Market Cap

$77M

P/E (Forward)

10.0x

Gross Margin

38.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 7775.T are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
7775.T	Daiken Medical Co., Ltd.(you)	$77M	77	BUY
7743.T	SEED Co.,Ltd.	$92M	81	STRONG BUY
4556.T	KAINOS Laboratories, Inc.	$62M	84	STRONG BUY
3154.T	Medius Holdings Co., Ltd.	$117M	71	BUY
7702.T	JMS Co.,Ltd.	$66M	62	HOLD
3446.T	JTEC Corporation	$67M	47	HOLD
368A.T	KITAZATO CORPORATION	$294M	86	STRONG BUY
5889.T	JAPAN EYEWEAR HOLDINGS CO LTD	$311M	87	STRONG BUY
197A.T	TAUNS LABORATORIES INC.	$326M	67	BUY
262A.T	INTERMESTIC INC	$399M	66	BUY

Peer medians: ROE 8.1% · P/E 15.6x · Gross margin 48.1%

Daiken Medical Co., Ltd. (7775.T) — Stock Score Summary

Daiken Medical Co., Ltd. (7775.T) has a MoatMap StockRank of 77/100 based on Quality (65/100), Value (51/100), and Momentum (49/100) factor scores. The current signal is BUY. Daiken Medical manufactures medical devices for the Japanese market. It lacks the global scale, CDMO pricing power, or reinvestment runway required for our strategy.

Key Financial Metrics

Price	$2.64
Market Cap	$77M
P/E (TTM)	13.08
P/E (Forward)	9.96
Price/Book	1.55
Return on Equity	12.1%
Return on Invested Capital	18.2%
Debt/Equity	29.17
Gross Margin	38.4%
Operating Margin	6.7%
Revenue Growth	5.4%
Free Cash Flow	$7K

Daiken Medical Co., Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Japan).

Frequently Asked Questions

What is Daiken Medical Co., Ltd.’s (7775.T) StockRank?: MoatMap’s StockRank for Daiken Medical Co., Ltd. (7775.T) is 77/100, with a Buy signal. It is a composite of Quality (65), Value (51), and Momentum (49) factor ranks across MoatMap’s 20,000+ stock universe.
Does Daiken Medical Co., Ltd. have an economic moat?: Daiken Medical Co., Ltd. (7775.T) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Daiken Medical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Daiken Medical Co., Ltd. (7775.T) is Buy, based on a StockRank of 77/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Daiken Medical Co., Ltd. in?: Daiken Medical Co., Ltd. (7775.T) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Japan).